Lassa fever epidemiology and demographics: Difference between revisions
| Line 6: | Line 6: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The dissemination of the infection can be assessed by [[prevalence]] of [[antibodies]] to the virus in | The dissemination of the [[infection]] can be assessed by [[prevalence]] of [[antibodies]] to the virus in [[population]]s of: | ||
*Sierra Leone 8–52% | *Sierra Leone 8–52% | ||
*Guinea 4–55% | *Guinea 4–55% | ||
Revision as of 14:04, 24 December 2012
|
Lassa fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lassa fever epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Lassa fever epidemiology and demographics |
|
Risk calculators and risk factors for Lassa fever epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Epidemiology and Demographics
Prevalence
The dissemination of the infection can be assessed by prevalence of antibodies to the virus in populations of:
- Sierra Leone 8–52%
- Guinea 4–55%
- Nigeria approx. 21%
The number of Lassa virus infections per year in West Africa is estimated at 100,000 to 300,000. Unfortunately, such estimates are crude, because surveillance for cases of the disease is not uniformly performed. In some areas of Sierra Leone and Liberia, it is known that 10%-16% of people admitted to hospitals have Lassa fever, which indicates the serious impact of the disease on the population of this region.